The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Jan. 26, 2021
Filed:
Dec. 15, 2017
Applicant:
Glaxosmithkline Intellectual Property Development Limited, Brentford, GB;
Inventors:
Martha Alicia De La Rosa, Research Triangle Park, NC (US);
Wieslaw Mieczyslaw Kazmierski, Research Triangle Park, NC (US);
Vicente Samano, Research Triangle Park, NC (US);
Assignee:
GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED, Middlesex, GB;
Primary Examiner:
Int. Cl.
CPC ...
C07D 417/12 (2006.01); C07D 417/14 (2006.01); C07D 405/12 (2006.01); C07D 285/08 (2006.01); C07D 241/06 (2006.01); C07D 233/88 (2006.01); C07D 233/90 (2006.01); C07D 213/04 (2006.01); C07D 249/14 (2006.01); C07D 237/20 (2006.01); C07C 229/42 (2006.01); C07D 207/50 (2006.01); C07D 213/74 (2006.01); C07D 235/00 (2006.01); C07D 235/30 (2006.01); C07D 241/20 (2006.01); C07D 257/06 (2006.01); C07D 263/48 (2006.01); C07D 271/113 (2006.01); C07D 277/42 (2006.01); C07D 277/82 (2006.01); C07D 305/08 (2006.01); C07D 333/36 (2006.01); C07D 335/02 (2006.01); C07D 413/12 (2006.01); C07D 417/04 (2006.01); C07D 471/04 (2006.01);
U.S. Cl.
CPC ...
C07D 417/12 (2013.01); C07C 229/42 (2013.01); C07D 207/50 (2013.01); C07D 213/04 (2013.01); C07D 213/74 (2013.01); C07D 233/88 (2013.01); C07D 233/90 (2013.01); C07D 235/00 (2013.01); C07D 235/30 (2013.01); C07D 237/20 (2013.01); C07D 241/06 (2013.01); C07D 241/20 (2013.01); C07D 249/14 (2013.01); C07D 257/06 (2013.01); C07D 263/48 (2013.01); C07D 271/113 (2013.01); C07D 277/42 (2013.01); C07D 277/82 (2013.01); C07D 285/08 (2013.01); C07D 305/08 (2013.01); C07D 333/36 (2013.01); C07D 335/02 (2013.01); C07D 405/12 (2013.01); C07D 413/12 (2013.01); C07D 417/04 (2013.01); C07D 417/14 (2013.01); C07D 471/04 (2013.01);
Abstract
Provided are IDO inhibitor compounds of Formula I and pharmaceutically acceptable salts thereof, their pharmaceutical compositions, their methods of preparation, and methods for their use in the prevention and/or treatment of diseases such as chronic viral infection, chronic bacterial infections, cancer, sepsis or a neurological disorder.